2020
Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry)
Saad M, Tobolski J, Kolte D, Wang Y, Minges K, Hira RS, Curtis JP, Abbott JD. Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry). The American Journal Of Cardiology 2020, 133: 182-184. PMID: 32819682, DOI: 10.1016/j.amjcard.2020.07.029.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAnticoagulantsCoronary Artery DiseaseDrug Administration ScheduleFemaleHumansMaleMiddle AgedPercutaneous Coronary InterventionPractice Patterns, Physicians'Purinergic P2Y Receptor AntagonistsPatient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain–MI Registry
Rodwin BA, Lu D, Giaimo A, Annapureddy A, Daggubati R, Curtis J, Sciria CT, Wang TY, Desai NR. Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain–MI Registry. International Journal Of Cardiology 2020, 304: 14-20. PMID: 31980270, DOI: 10.1016/j.ijcard.2020.01.029.Peer-Reviewed Original ResearchMeSH KeywordsChest PainHospitalsHumansMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsRegistriesTicagrelorTreatment OutcomeConceptsChest Pain-MI RegistryAcute myocardial infarctionTicagrelor useHospital characteristicsACC/AHA guidelinesUse of ticagrelorUse of clopidogrelHealth system performanceAHA guidelinesAcute MIHighest quartileAMI patientsInhibitor clopidogrelMI patientsMyocardial infarctionMultivariable modelWhite racePrasugrelPatientsTicagrelorHospitalPrivate insuranceClopidogrelP2YRegistry
2014
In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions 2014, 7: 585-593. PMID: 25097196, DOI: 10.1161/circinterventions.114.001555.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAge FactorsAgedClopidogrelDrug SubstitutionFemaleHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPiperazinesPostoperative ComplicationsPractice Guidelines as TopicPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsRecurrenceRegistriesRisk FactorsThiophenesThrombosisTiclopidineUnited StatesConceptsPercutaneous coronary interventionMyocardial infarctionCoronary interventionHospital coronary artery bypassIntervention Outcomes Network RegistryStudy periodAcute Coronary TreatmentHierarchical logistic regression modelingCoronary artery bypassRecurrent ischemic eventsHours of admissionPrevious cerebrovascular eventsRandomized clinical trialsAcute myocardial infarctionADP receptor inhibitorsLogistic regression modelingPrivate health insurance coverageHealth insurance coverageHospital bleedingHospital switchingAngiographic characteristicsArtery bypassCerebrovascular eventsContemporary US practiceCoronary Treatment